News & events

Research and company
updates.

Selected publications, recognition, and conversations across the life sciences community.

October2026

Alyssa Nicholas joins NanomediGene as Investor Relations Lead.

Alyssa Nicholas joins NanomediGene on October 12, 2026, as Investor Relations Lead, supporting investor communications, outreach coordination, and follow-up.

An MBA candidate at Yale School of Management and a two-time healthtech founder, Alyssa brings experience in healthcare consulting, venture capital, and diagnostics.

Meet Alyssa
NanomediGene welcomes Alyssa Nicholas as Investor Relations Lead
October2026October 22

BIO Alabama 2026 Annual Conference

NanomediGene presented
at BIO Alabama 2026.

Founder and CEO Yasin Oduk, Ph.D., presented NanomediGene’s metabolic oncology program at the BIO Alabama Annual Conference on October 22, 2026, at Renaissance Ross Bridge in Hoover, Alabama. The presentation introduced NMG’s ACC-inhibitor formulation program and its initial focus on treatment-resistant triple-negative breast cancer.

Read Yasin’s LinkedIn recap
Yasin Oduk presenting NanomediGene onstage at the BIO Alabama Annual Conference on October 22, 2026
September2026Boston, MA

J.P. Morgan Life Sciences & Healthcare Innovator Summit

Joining the biotech conversation
at Harvard Medical School.

NanomediGene founder Yasin Oduk attended the J.P. Morgan Life Sciences & Healthcare Innovator Summit at Harvard Medical School in Boston on September 10, 2026. He joined researchers, founders, and investors for discussions on biotechnology development and company building, and raised a question about financing the early data needed to advance a biotech program.

Read Yasin’s LinkedIn recap
August2026

Shan et al. (2026): ACC inhibition, combinations and resistance.

Shan et al., with Lajos Pusztai as senior author, examine the ACC inhibitor PF-05175157, cellular stress, and potential anticancer combinations in preclinical models. Published in Clinical Cancer Research.

Read our research feature
May2026

Best Biotech in the E-Poster category

NanomediGene received Best Biotech in the E-Poster category at the 2026 Yale Innovation Summit, held May 27–28.

Official award announcement
Award presentation at the 2026 Yale Innovation Summit
May2026

BioNJ BioPartnering Conference

NanomediGene was listed among presenting companies at Liberty Science Center in Jersey City.

BioNJ presenting companies
June2024

Building at BioLabs New Haven

Our New Haven laboratory supports formulation development and connects the company with the local life sciences community.

See Yasin’s laboratory postAbout NMG
BioLabs New Haven building shared by Yasin Oduk

Work with us

Continue the conversation.

Follow NanomediGene’s development and connect with our team.

Start a conversation